NeueHealth, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NeueHealth, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • NeueHealth, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$58.6M, a 48% increase year-over-year.
  • NeueHealth, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$938M, a 26.3% increase year-over-year.
  • NeueHealth, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.15B, a 20.9% increase from 2022.
  • NeueHealth, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$1.46B, a 22.8% decline from 2021.
  • NeueHealth, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.18B, a 377% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$938M -$58.6M +$54.2M +48% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$992M -$15.9M +$159M +90.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$1.15B -$230M +$439M +65.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$1.59B -$634M -$317M -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$1.27B -$113M +$162M +58.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.44B -$175M +$20.2M +10.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$1.46B -$669M +$146M +17.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$1.6B -$317M -$16.2M -5.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.59B -$275M -$230M -517% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$1.35B -$195M -$170M -676% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$1.18B -$815M -$651M -397% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$534M -$301M -$241M -407% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$293M -$44.5M -$26.4M -146% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$266M -$25.2M -$17.9M -246% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$248M -$164M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$59.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$18.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$7.28M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.